1. Academic Validation
  2. N6-methyl-AMP aminohydrolase activates N6-substituted purine acyclic nucleoside phosphonates

N6-methyl-AMP aminohydrolase activates N6-substituted purine acyclic nucleoside phosphonates

  • Biochem Pharmacol. 2006 Apr 28;71(9):1370-6. doi: 10.1016/j.bcp.2006.01.013.
Markéta Schinkmanová 1 Ivan Votruba Antonín Holý
Affiliations

Affiliation

  • 1 Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague 6, Czech Republic. [email protected]
Abstract

In this study we present the identification and characterization of the enzyme involved in the N6-cyclopropyl-2,6-diamino-9-[2-(phosphonomethoxy)ethyl]purine (N6-cyclopropyl-PMEDAP) conversion to biologically active 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG) as well as abacavir 5'-phosphate to carbovir 5'-phosphate. This enzyme was purified from rat liver to homogeneity; it appears to be composed from six 42 kDa subunits and its native form has the molecular weight 260 kDa. This so far unknown enzyme catalyzes conversion of both N6-methyl-AMP and N6-methyl-dAMP to IMP and/or dIMP, respectively. The enzyme acts as 6-(N-substituted amino)purine 5'-nucleotide aminohydrolase with the reaction mechanism very similar to AMP deaminase. The enzyme does not deaminate AMP and dAMP, or the corresponding nucleosides. It is inhibited by deoxycoformycin 5'-phosphate but not by deoxycoformycin or erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA).

Figures
Products